BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Román ALS, Muñoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol 2011; 17(22): 2723-2733 [PMID: 21734780 DOI: 10.3748/wjg.v17.i22.2723]
URL: https://www.wjgnet.com/1007-9327/full/v17/i22/2723.htm
Number Citing Articles
1
Hanna Öhlmann, Laura Ricarda Koenen, Franziska Labrenz, Harald Engler, Nina Theysohn, Jost Langhorst, Sigrid Elsenbruch. Altered Brain Structure in Chronic Visceral Pain: Specific Differences in Gray Matter Volume and Associations With Visceral Symptoms and Chronic StressFrontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.733035
2
G. Conway, G. Velonias, E. Andrews, J. J. Garber, V. Yajnik, A. N. Ananthakrishnan. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseasesAlimentary Pharmacology & Therapeutics 2017; 45(6): 814 doi: 10.1111/apt.13940
3
Kendra J. Kamp, Manfred Stommel. Health-Related Quality of Life Among Patients With Inflammatory Bowel DiseaseGastroenterology Nursing 2021; 44(1): 21 doi: 10.1097/SGA.0000000000000491
4
Fang Xu, James M. Dahlhamer, Emily P. Terlizzi, Anne G. Wheaton, Janet B. Croft. Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015–2016Digestive Diseases and Sciences 2019; 64(7): 1798 doi: 10.1007/s10620-019-05494-w
5
Fang Xu, Anne G. Wheaton, Kamil E. Barbour, Yong Liu, Kurt J. Greenlund. Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000–2017Digestive Diseases and Sciences 2021; 66(6): 1818 doi: 10.1007/s10620-020-06476-z
6
Hubert Zatorski, Maciej Sałaga, Jakub Fichna. Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectivesNaunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(11): 1321 doi: 10.1007/s00210-019-01698-z
7
Adrian L Lopresti. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?Advances in Nutrition 2018; 9(1): 41 doi: 10.1093/advances/nmx011
8
Mohamed A. Morsy, Hanaa M. Khalaf, Rehab A. Rifaai, Asmaa M.A. Bayoumi, Esraa M.M.A. Khalifa, Yasmine F. Ibrahim. Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2Biomedicine & Pharmacotherapy 2021; 141: 111902 doi: 10.1016/j.biopha.2021.111902
9
Walter Reinisch, Krisztina Gecse, Jonas Halfvarson, Peter M Irving, Jørgen Jahnsen, Laurent Peyrin-Biroulet, Gerhard Rogler, Stefan Schreiber, Silvio Danese. Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s DiseaseInflammatory Bowel Diseases 2021; 27(1): 106 doi: 10.1093/ibd/izaa078
10
Joana Costa Antunes, Catarina Leal Seabra, Joana Margarida Domingues, Marta Oliveira Teixeira, Cláudia Nunes, Sofia Antunes Costa-Lima, Natália Cândido Homem, Salette Reis, Maria Teresa Pessoa Amorim, Helena Prado Felgueiras. Drug Targeting of Inflammatory Bowel Diseases by BiomoleculesNanomaterials 2021; 11(8): 2035 doi: 10.3390/nano11082035
11
Anna Campanati, Andrea Marani, Emanuela Martina, Federico Diotallevi, Giulia Radi, Annamaria Offidani. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic ApproachesBiomedicines 2021; 9(11): 1511 doi: 10.3390/biomedicines9111511
12
Akbar K. Waljee, Mohamed Noureldin, Jeffrey A. Berinstein, Shirley A. Cohen-Mekelburg, Beth I. Wallace, Kelly C. Cushing, David A. Hanauer, Toby P. Keeney-Bonthrone, Brahmajee Nallamothu, Peter D.R. Higgins. Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsEuropean Journal of Gastroenterology & Hepatology 2020; 32(10): 1341 doi: 10.1097/MEG.0000000000001869
13
Benjamin Click, David G. Binion, Alyce M. Anderson. Predicting Costs of Care for Patients With Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology 2017; 15(3): 393 doi: 10.1016/j.cgh.2016.11.027
14
David T. Okou, Subra Kugathasan. Role of Genetics in Pediatric Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2014; 20(10): 1878 doi: 10.1097/MIB.0000000000000085
15
Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related SyndromesJournal of Clinical Medicine 2019; 8(4): 493 doi: 10.3390/jcm8040493
16
Jesus E. Juarez, Tahmineh Romero, Constantine A. Mantz, Abigail Pepin, Nima Aghdam, Simeng Suy, Michael L. Steinberg, Rebecca G. Levin-Epstein, Nicholas G. Nickols, Irving D. Kaplan, Robert M. Meier, Huong T. Pham, Patrick W. Linson, Robert L. Hong, Mark K. Buyyounouski, Hilary P. Bagshaw, Donald B. Fuller, Alan J. Katz, Andrew Loblaw, Sean P. Collins, Amar U. Kishan. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control SeriesAdvances in Radiation Oncology 2021; 6(6): 100759 doi: 10.1016/j.adro.2021.100759
17
Motasem Alkhayyat, Mohammad Abureesh, Arshpal Gill, George Khoudari, Mohannad Abou Saleh, Emad Mansoor, Miguel Regueiro. Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF TherapyInflammatory Bowel Diseases 2021; 27(7): 1052 doi: 10.1093/ibd/izaa252
18
Motasem Alkhayyat, Mohammad Abureesh, Ashraf Almomani, Mohannad Abou Saleh, Mohammad Zmaili, Sara El Ouali, Emad Mansoor, Alberto Rubio-Tapia, Miguel Regueiro. Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac DiseaseInflammatory Bowel Diseases 2021;  doi: 10.1093/ibd/izab084
19
Tessa E. H. Römkens, Rene te Morsche, Wilbert Peters, David M. Burger, Frank Hoentjen, Joost P. H. Drenth. Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practiceBritish Journal of Clinical Pharmacology 2018; 84(3): 477 doi: 10.1111/bcp.13462
20
Paulina Nuñez, Sandra García Mateo, Rodrigo Quera, Fernando Gomollón. La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascularGastroenterología y Hepatología 2021; 44(3): 236 doi: 10.1016/j.gastrohep.2020.09.002
21
Jiayu Ye, Natasha Haskey, Hansika Dadlani, Hatem Zubaidi, Jacqueline A. Barnett, Sanjoy Ghosh, Deanna L. Gibson. Deletion of mucin 2 induces colitis with concomitant metabolic abnormalities in miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(5): G791 doi: 10.1152/ajpgi.00277.2020
22
Hubert Zatorski, Maciej Salaga, Marta Zielińska, Anna Mokrowiecka, Damian Jacenik, Wanda Małgorzata Krajewska, Ewa Małecka-Panas, Jakub Fichna. Colonic inflammation induces changes in glucose levels through modulation of incretin systemPharmacological Reports 2021;  doi: 10.1007/s43440-021-00327-y
23
Benjamin Click, Claudia Ramos Rivers, Ioannis E. Koutroubakis, Dmitriy Babichenko, Alyce M. Anderson, Jana G. Hashash, Michael A. Dunn, Marc Schwartz, Jason Swoger, Leonard Baidoo, Arthur Barrie, Miguel Regueiro, David G. Binion. Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2016; 22(6): 1442 doi: 10.1097/MIB.0000000000000763
24
Paola Conigliaro, Maria Sole Chimenti, Marta Ascolani, Paola Triggianese, Lucia Novelli, Sara Onali, Elisabetta Lolli, Emma Calabrese, Carmelina Petruzziello, Francesco Pallone, Roberto Perricone, Livia Biancone. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patientsAutoimmunity Reviews 2016; 15(2): 184 doi: 10.1016/j.autrev.2015.11.002
25
K T Park, Richard B Colletti, David T Rubin, Bal K Sharma, Amy Thompson, Andrew Krueger. Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn’s Disease in the United StatesAmerican Journal of Gastroenterology 2016; 111(1): 15 doi: 10.1038/ajg.2015.207
26
Maria Izabel Siqueira de ANDRADE, Regiane MAIO, Keila Fernandes DOURADO, Patrícia Fortes Cavalcanti de MACÊDO, Augusto César BARRETO NETO. EXCESSIVE WEIGHT – MUSCLE DEPLETION PARADOX AND CARDIOVASCULAR RISK FACTORS IN OUTPATIENTS WITH INFLAMMATORY BOWEL DISEASEArquivos de Gastroenterologia 2015; 52(1): 37 doi: 10.1590/S0004-28032015000100009
27
Fang Xu, James M. Dahlhamer, Emily P. Zammitti, Anne G. Wheaton, Janet B. Croft. Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease — United States, 2015 and 2016MMWR. Morbidity and Mortality Weekly Report 2018; 67(6): 190 doi: 10.15585/mmwr.mm6706a4
28
Che-Yung Chao, Robert Battat, Alex Al Khoury, Sophie Restellini, Giada Sebastiani, Talat Bessissow. Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review articleWorld Journal of Gastroenterology 2016; 22(34): 7727-7734 doi: 10.3748/wjg.v22.i34.7727
29
Ignacio Marin-Jimenez, Guillermo Bastida, Ana Forés, Esther Garcia-Planella, Federico Argüelles-Arias, Pilar Sarasa, Ignacio Tagarro, Alonso Fernández-Nistal, Carmen Montoto, Mariam Aguas, Javier Santos-Fernández, Marta Maia Bosca-Watts, Rocio Ferreiro, Olga Merino, Xavier Aldeguer, Xavier Cortés, Beatriz Sicilia, Francisco Mesonero, Manuel Barreiro-de Acosta. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE studyBMJ Open Gastroenterology 2020; 7(1): e000351 doi: 10.1136/bmjgast-2019-000351
30
Talat Bessissow, Ngoc Han Le, Kathleen Rollet, Waqqas Afif, Alain Bitton, Giada Sebastiani. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2016; 22(8): 1937 doi: 10.1097/MIB.0000000000000832
31
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield, Gemma Marceniuk. Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness studyHealth Technology Assessment 2021; 25(23): 1 doi: 10.3310/hta25230
32
Marco Vincenzo Lenti, Alessandro Armuzzi, Fabiana Castiglione, Massimo Claudio Fantini, Gionata Fiorino, Ambrogio Orlando, Daniela Pugliese, Fernando Rizzello, Maurizio Vecchi, Antonio Di Sabatino. Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaignDigestive and Liver Disease 2020; 52(1): 44 doi: 10.1016/j.dld.2019.09.019
33
Webber Chan, Viraj C. Kariyawasam, Shin Kim, Aviv V. Pudipeddi, Sudarshan Paramsothy, Hang Hock Shim, Fadi H. Mourad, Nik Ding, Marc Ferrante, Rupert W. Leong. Gastroenterologists’ preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international surveyEuropean Journal of Gastroenterology & Hepatology 2020; 32(8): 976 doi: 10.1097/MEG.0000000000001768
34
Chang-Kee Hyun. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel DiseasesInternational Journal of Molecular Sciences 2021; 22(17): 9139 doi: 10.3390/ijms22179139
35
Camilo Obando, Zhijie Ding, Erik Muser, Neel Vaidya, Wenqin Qiang, Xiaoxi Sun, Huiqi Wang, Rajesh Mallampati, Lin Xie. Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United StatesAdvances in Therapy 2020; 37(5): 2127 doi: 10.1007/s12325-020-01276-3
36
Fang Xu, Yong Liu, Anne G. Wheaton, Kristina M. Rabarison, Janet B. Croft. Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United StatesApplied Health Economics and Health Policy 2019; 17(1): 77 doi: 10.1007/s40258-018-0432-4
37
Paulina Nuñez, Sandra García Mateo, Rodrigo Quera, Fernando Gomollón. Inflammatory bowel disease and the risk of cardiovascular diseasesGastroenterología y Hepatología (English Edition) 2021; 44(3): 236 doi: 10.1016/j.gastre.2021.02.003
38
Viraj C Kariyawasam, Shin Kim, Fadi H Mourad, Christian P Selinger, Peter H Katelaris, D Brian Jones, Charles McDonald, Gavin Barr, Grace Chapman, James Colliwshaw, Paul C Lunney, Kate Middleton, Rosy R Wang, Tony Huang, Jane Andrews, Priyanthi W Pathirana, Rupert W Leong. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2019; 25(8): 1390 doi: 10.1093/ibd/izy389
39
Eleonora Scaioli, Andrea Belluzzi, Luigi Ricciardiello, Daniele Del Rio, Enrica Rotondo, Pedro Mena, Eleonora Derlindati, Francesca Danesi. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trialTrials 2019; 20(1) doi: 10.1186/s13063-019-3321-8
40
Charles N. Bernstein, Zoann Nugent, Seth Shaffer, Harminder Singh, Ruth Ann Marrie. Comorbidity before and after a diagnosis of inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2021; 54(5): 637 doi: 10.1111/apt.16444
41
Marla C Dubinsky, Raymond K Cross, William J Sandborn, Millie Long, Xue Song, Nianwen Shi, Yao Ding, Samantha Eichner, Brandee Pappalardo, Arijit Ganguli, Anthony Wang. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2018; 24(9): 1876 doi: 10.1093/ibd/izy065
42
Petra Černá, Scott Kilpatrick, Danielle A Gunn-Moore. Feline comorbidities: What do we really know about feline triaditis?Journal of Feline Medicine and Surgery 2020; 22(11): 1047 doi: 10.1177/1098612X20965831
43
Åsa H Everhov, Hamed Khalili, Johan Askling, Pär Myrelid, Jonas F Ludvigsson, Jonas Halfvarson, Caroline Nordenvall, Martin Neovius, Jonas Söderling, Ola Olén. Work Loss Before and After Diagnosis of Crohn’s DiseaseInflammatory Bowel Diseases 2019; 25(7): 1237 doi: 10.1093/ibd/izy382
44
Ashwin N. Ananthakrishnan, Tamara Donaldson, Karen Lasch, Vijay Yajnik. Management of Inflammatory Bowel Disease in the Elderly PatientInflammatory Bowel Diseases 2017; 23(6): 882 doi: 10.1097/MIB.0000000000001099
45
Martha Bayliss, Regina Rendas-Baum, Michelle K White, Mark Maruish, Jakob Bjorner, Sandra L Tunis. Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or mental health conditions: panel survey of an adult sample in the United StatesHealth and Quality of Life Outcomes 2012; 10(1) doi: 10.1186/1477-7525-10-154
46
Wolf-Henning Boehncke. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and ConsequencesFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00579
47
Jami Kinnucan, David Binion, Raymond Cross, Elisabeth Evans, Kevin Harlen, Laura Matarese, Amy Mullins, Bud O’Neal, Marci Reiss, Frank I. Scott, Alandra Weaver, Jonathan Rosenberg. Inflammatory Bowel Disease Care Referral PathwayGastroenterology 2019; 157(1): 242 doi: 10.1053/j.gastro.2019.03.064
48
Aristo Vojdani, Elroy Vojdani, Martha Herbert, Datis Kharrazian. Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCAInternational Journal of Molecular Sciences 2020; 21(4): 1381 doi: 10.3390/ijms21041381
49
Ben Wilkinson, Leanne Trick, Annie Knight, Vincent Valton, James Goodhand, Nick A. Kennedy, Neel Heerasing, Tariq Ahmad, Amy Bland, Rebecca Elliott, Jonathan P. Roiser, Chris Dickens. Factors associated with depression in people with inflammatory bowel disease: The relationship between active disease and biases in neurocognitive processingNeurogastroenterology & Motility 2019; 31(8) doi: 10.1111/nmo.13647
50
Seymour Katz, Yingheng Liu. Geriatric Gastroenterology2021; : 1675 doi: 10.1007/978-3-030-30192-7_66
51
Jordana L. Sommer, Renée El-Gabalawy, Natalie Mota. Understanding the association between posttraumatic stress disorder characteristics and physical health conditions: A population-based studyJournal of Psychosomatic Research 2019; 126: 109776 doi: 10.1016/j.jpsychores.2019.109776
52
Seymour Katz, Yingheng Liu. Geriatric Gastroenterology2020; : 1 doi: 10.1007/978-3-319-90761-1_66-1
53
Helga Radner. Multimorbidity in rheumatic conditionsWiener klinische Wochenschrift 2016; 128(21-22): 786 doi: 10.1007/s00508-016-1090-x
54
Marjorie Argollo, Daniela Gilardi, Carina Peyrin-Biroulet, Jean-Francois Chabot, Laurent Peyrin-Biroulet, Silvio Danese. Comorbidities in inflammatory bowel disease: a call for actionThe Lancet Gastroenterology & Hepatology 2019; 4(8): 643 doi: 10.1016/S2468-1253(19)30173-6